Financhill
Buy
81

CBL Quote, Financials, Valuation and Earnings

Last price:
$27.15
Seasonality move :
-4.36%
Day range:
$27.06 - $27.64
52-week range:
$20.97 - $33.54
Dividend yield:
5.81%
P/E ratio:
14.72x
P/S ratio:
1.65x
P/B ratio:
2.63x
Volume:
84.8K
Avg. volume:
177.8K
1-year change:
22.85%
Market cap:
$851.7M
Revenue:
$515.6M
EPS (TTM):
$1.87

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, CBL & Associates Properties has 30.77% upside to fair value with a price target of -- per share.

CBL vs. S&P 500

  • Over the past 5 trading days, CBL & Associates Properties has underperformed the S&P 500 by -1.4% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • CBL & Associates Properties does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • CBL & Associates Properties revenues have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter CBL & Associates Properties reported revenues of $131.7M.

Earnings Growth

  • CBL & Associates Properties has grown year-over-year earnings for 2 quarters straight. In the most recent quarter CBL & Associates Properties reported earnings per share of $1.22.
Enterprise value:
2.8B
EV / Invested capital:
1.10x
Price / LTM sales:
1.65x
EV / EBIT:
13.31x
EV / Revenue:
5.37x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
13.70x
Price / Operating cash flow:
4.22x
Enterprise value / EBITDA:
7.60x
Gross Profit (TTM):
$340.4M
Return On Assets:
2.44%
Net Income Margin (TTM):
11.44%
Return On Equity:
18.96%
Return On Invested Capital:
2.65%
Operating Margin:
30.19%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $563M $535.3M $515.6M $139.7M $131.7M
Gross Profit $371.3M $348.1M $340.4M $94.4M $88M
Operating Income $46.9M $93.4M $132.3M $37.7M $39.8M
EBITDA $398M $390.2M $364.3M $102.4M $110.9M
Diluted EPS -$3.23 $0.17 $1.87 $0.37 $1.22
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $408.8M $583.8M $650.1M $431.4M $500.9M
Total Assets $4.4B $2.9B $2.7B $2.4B $2.7B
Current Liabilities $843.3M $184.4M $200.3M $186.5M $221.6M
Total Liabilities $3.9B $2.5B $2.3B $2.1B $2.4B
Total Equity $534M $401.1M $367.1M $330.6M $312.9M
Total Debt $3.7B -- $2B $1.9B $2.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $208.2M $183.5M $202.2M $49.4M $46.2M
Cash From Investing -$156.7M $1.7M $65M -$16.4M $7.4M
Cash From Financing -$145.8M -$204.1M -$236.5M -$29.6M -$41.3M
Free Cash Flow $208.2M $183.5M $202.2M $49.4M $46.2M
CBL
Sector
Market Cap
$851.7M
$1B
Price % of 52-Week High
82.09%
80.31%
Dividend Yield
5.81%
3.33%
Shareholder Yield
2.56%
3.41%
1-Year Price Total Return
22.85%
-1.98%
Beta (5-Year)
--
0.886
Dividend yield:
5.81%
Annualized payout:
$1.60
Payout ratio:
85.39%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $27.76
200-day SMA
Buy
Level $27.19
Bollinger Bands (100)
Sell
Level 27.81 - 31.11
Chaikin Money Flow
Sell
Level -2.7M
20-day SMA
Sell
Level $29.63
Relative Strength Index (RSI14)
Sell
Level 36.83
ADX Line
Sell
Level 29.63
Williams %R
Neutral
Level -73.5374
50-day SMA
Sell
Level $29.75
MACD (12, 26)
Sell
Level -0.88
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Sell
Level -1.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.5982)
Sell
CA Score (Annual)
Level (-1.7202)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.7921)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

Stock Forecast FAQ

In the current month, CBL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CBL average analyst price target in the past 3 months is --.

  • Where Will CBL & Associates Properties Stock Be In 1 Year?

    According to analysts, the consensus estimate is that CBL & Associates Properties share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About CBL & Associates Properties?

    Analysts are divided on their view about CBL & Associates Properties share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CBL & Associates Properties is a Sell and believe this share price will drop from its current level to --.

  • What Is CBL & Associates Properties's Price Target?

    The price target for CBL & Associates Properties over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CBL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for CBL & Associates Properties is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CBL?

    You can purchase shares of CBL & Associates Properties via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CBL & Associates Properties shares.

  • What Is The CBL & Associates Properties Share Price Today?

    CBL & Associates Properties was last trading at $27.15 per share. This represents the most recent stock quote for CBL & Associates Properties. Yesterday, CBL & Associates Properties closed at $27.53 per share.

  • How To Buy CBL & Associates Properties Stock Online?

    In order to purchase CBL & Associates Properties stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock